Business Description
![Cell Source Inc Cell Source Inc logo](https://static.gurufocus.com/logos/0C0000AJZI.png?14)
Cell Source Inc
NAICS : 325413
SIC : 2834
ISIN : US15114L1044
Description
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. Its other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched and mismatched organ transplantation.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -80.06 | |||||
Debt-to-Equity | -0.59 | |||||
Debt-to-EBITDA | -2.17 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 3.3 | |||||
3-Year EPS without NRI Growth Rate | 3.3 | |||||
3-Year FCF Growth Rate | 13.3 | |||||
3-Year Book Growth Rate | -17.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 8.66 | |||||
9-Day RSI | 18.26 | |||||
14-Day RSI | 26.56 | |||||
6-1 Month Momentum % | -99.83 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7 | |||||
Shareholder Yield % | -7055.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.17 | |||||
EV-to-EBITDA | -2.17 | |||||
EV-to-FCF | -3.95 | |||||
Earnings Yield (Greenblatt) % | -46.08 | |||||
FCF Yield % | -7115.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CLCS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cell Source Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.16 | ||
Beta | -254.16 | ||
Volatility % | 22091.96 | ||
14-Day RSI | 26.56 | ||
14-Day ATR ($) | 0.002985 | ||
20-Day SMA ($) | 0.0008 | ||
12-1 Month Momentum % | 100 | ||
52-Week Range ($) | 0.0002 - 0.74 | ||
Shares Outstanding (Mil) | 41.02 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cell Source Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cell Source Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cell Source Inc Frequently Asked Questions
What is Cell Source Inc(CLCS)'s stock price today?
The current price of CLCS is $0.00. The 52 week high of CLCS is $0.74 and 52 week low is $0.00.
When is next earnings date of Cell Source Inc(CLCS)?
The next earnings date of Cell Source Inc(CLCS) is .
Does Cell Source Inc(CLCS) pay dividends? If so, how much?
Cell Source Inc(CLCS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |